2099 related articles for article (PubMed ID: 23302120)
41. Introduction of the QF-PCR analysis for the purposes of prenatal diagnosis in Bulgaria--estimation of applicability of 6 STR markers on chromosomes 21 and 18.
Andonova S; Vazharova R; Dimitrova V; Mazneikova V; Toncheva D; Kremensky I
Prenat Diagn; 2004 Mar; 24(3):202-8. PubMed ID: 15057954
[TBL] [Abstract][Full Text] [Related]
42. Analysis of multiple loci can increase reliability of detection of fetal Y-chromosome DNA in maternal plasma.
Wagner J; Dzijan S; Pavan-Jukić D; Wagner J; Lauc G
Prenat Diagn; 2008 May; 28(5):412-6. PubMed ID: 18395868
[TBL] [Abstract][Full Text] [Related]
43. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.
Ashoor G; Syngelaki A; Wagner M; Birdir C; Nicolaides KH
Am J Obstet Gynecol; 2012 Apr; 206(4):322.e1-5. PubMed ID: 22464073
[TBL] [Abstract][Full Text] [Related]
44. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18.
Wataganara T; LeShane ES; Farina A; Messerlian GM; Lee T; Canick JA; Bianchi DW
Hum Genet; 2003 Feb; 112(2):204-8. PubMed ID: 12522563
[TBL] [Abstract][Full Text] [Related]
45. Aneuploidy screening by non-invasive prenatal testing in twin pregnancy.
Fosler L; Winters P; Jones KW; Curnow KJ; Sehnert AJ; Bhatt S; Platt LD
Ultrasound Obstet Gynecol; 2017 Apr; 49(4):470-477. PubMed ID: 27194226
[TBL] [Abstract][Full Text] [Related]
46. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
[TBL] [Abstract][Full Text] [Related]
47. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
[TBL] [Abstract][Full Text] [Related]
48. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.
Gil MM; Quezada MS; Bregant B; Ferraro M; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):34-40. PubMed ID: 23744609
[TBL] [Abstract][Full Text] [Related]
49. Detection of mosaicism for primary trisomies in prenatal samples by QF-PCR and karyotype analysis.
Donaghue C; Mann K; Docherty Z; Ogilvie CM
Prenat Diagn; 2005 Jan; 25(1):65-72. PubMed ID: 15662691
[TBL] [Abstract][Full Text] [Related]
50. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.
Lau TK; Jiang FM; Stevenson RJ; Lo TK; Chan LW; Chan MK; Lo PS; Wang W; Zhang HY; Chen F; Choy KW
Prenat Diagn; 2013 Jun; 33(6):602-8. PubMed ID: 23553438
[TBL] [Abstract][Full Text] [Related]
51. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
[TBL] [Abstract][Full Text] [Related]
52. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
[TBL] [Abstract][Full Text] [Related]
53. Refined fluorescent STR quantification of cell-free fetal DNA during pregnancy in physiological and Down syndrome fetuses.
Vodicka R; Vrtel R; Dusek L; Prochazka M; Schneiderova E; Vrbicka D; Krejcirikova E; Dhaifalah I; Santava A; Santavy J
Prenat Diagn; 2008 May; 28(5):425-33. PubMed ID: 18395872
[TBL] [Abstract][Full Text] [Related]
54. Should cell-free fetal DNA be included in first trimester screening (FTS) for common trisomy? A possible scenario on 6697 women screened over 10 years.
Rosignoli L; Tonni G
J Eval Clin Pract; 2016 Dec; 22(6):899-906. PubMed ID: 27345561
[TBL] [Abstract][Full Text] [Related]
55. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
56. Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood.
Zhang B; Lu BY; Yu B; Zheng FX; Zhou Q; Chen YP; Zhang XQ
J Int Med Res; 2017 Apr; 45(2):621-630. PubMed ID: 28357876
[TBL] [Abstract][Full Text] [Related]
57. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia.
Santacroce R; Vecchione G; Tomaiyolo M; Sessa F; Sarno M; Colaizzo D; Grandone E; Margaglione M
Haemophilia; 2006 Jul; 12(4):417-22. PubMed ID: 16834744
[TBL] [Abstract][Full Text] [Related]
58. Fetal gender determination using real-time quantitative polymerase chain reaction analysis of maternal plasma.
Hwa HL; Ko TM; Yen ML; Chiang YL
J Formos Med Assoc; 2004 May; 103(5):364-8. PubMed ID: 15216403
[TBL] [Abstract][Full Text] [Related]
59. Multiplex fluorescent PCR for noninvasive prenatal detection of fetal-derived paternally inherited diseases using circulatory fetal DNA in maternal plasma.
Tang DL; Li Y; Zhou X; Li X; Zheng F
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):35-9. PubMed ID: 19285775
[TBL] [Abstract][Full Text] [Related]
60. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study.
Dhallan R; Guo X; Emche S; Damewood M; Bayliss P; Cronin M; Barry J; Betz J; Franz K; Gold K; Vallecillo B; Varney J
Lancet; 2007 Feb; 369(9560):474-81. PubMed ID: 17292767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
